{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T21:58:07Z","timestamp":1781819887283,"version":"3.54.5"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["# 2014\/50315-0"],"award-info":[{"award-number":["# 2014\/50315-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      American cutaneous leishmaniasis (ACL) is a protozoan parasitic disease caused by different\n                      <jats:italic>Leishmania<\/jats:italic>\n                      spp. from\n                      <jats:italic>L.<\/jats:italic>\n                      (\n                      <jats:italic>Leishmania<\/jats:italic>\n                      ) and\n                      <jats:italic>L.<\/jats:italic>\n                      (\n                      <jats:italic>Viannia<\/jats:italic>\n                      ) subgenera. In Brazil, seven\n                      <jats:italic>Leishmania<\/jats:italic>\n                      spp. act as ACL agents. Infection with\n                      <jats:italic>L.<\/jats:italic>\n                      (\n                      <jats:italic>L.<\/jats:italic>\n                      )\n                      <jats:italic>amazonensis<\/jats:italic>\n                      presents a wide clinical\u2013immunopathological spectrum, ranging from localized cutaneous leishmaniasis (LCL), which usually responds well to antimony therapy, to borderline disseminated cutaneous leishmaniasis (BDCL), which may require twice as much LCL-antimony therapy to cure, and, finally, to anergic diffuse cutaneous leishmaniasis (ADCL), which is highly resistant to any chemotherapy. This clinical variability is driven by different degrees of T-cell immunosuppression, which negatively impact delayed-type hypersensitivity (DTH), as assessed by the Montenegro skin test (MST).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Given MST\u2019s role as a T-cell-mediated resistance marker, we used it for diagnosing and monitoring patients with LCL (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20098) and BDCL (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20093) due to\n                      <jats:italic>L.<\/jats:italic>\n                      (\n                      <jats:italic>L.<\/jats:italic>\n                      )\n                      <jats:italic>amazonensis<\/jats:italic>\n                      to assess T-cell immunosuppression in these patients. MST was assessed at diagnosis and after treatment, although one patient with LCL refused treatment. The study took place at the Evandro Chagas Institute (Par\u00e1, Brazil), with diagnosis confirmed through parasitological assays, MST using\n                      <jats:italic>L.<\/jats:italic>\n                      (\n                      <jats:italic>V.<\/jats:italic>\n                      )\n                      <jats:italic>braziliensis<\/jats:italic>\n                      antigen, indirect fluorescent antibody test (IFAT)-immunoglobulin (Ig)G serology, histopathology, and PCR. Phenotypic and genotypic analyses were used to identify the primary agent.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>MST was negative in all patients, both before and after successful treatment. Notably, one patient with LCL who declined treatment also showed no MST reactivity both before and after spontaneous healing. The absence of MST reactivity persisted for up to 1 year postcure in LCL and up to 2 years in BDCL, indicating a sustained lack of MST reactivity regardless of treatment outcome or spontaneous healing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      The lack of MST reactivity pre- and post-treatment in LCL and BDCL challenges the role of DTH as a marker for T-cell-mediated resistance to\n                      <jats:italic>L.<\/jats:italic>\n                      (\n                      <jats:italic>L.<\/jats:italic>\n                      )\n                      <jats:italic>amazonensis<\/jats:italic>\n                      infection. Moreover, the first case of spontaneous LCL cure by\n                      <jats:italic>L.<\/jats:italic>\n                      (\n                      <jats:italic>L.<\/jats:italic>\n                      )\n                      <jats:italic>amazonensis<\/jats:italic>\n                      showed no MST reactivity pre- or post-resolution, raising doubts about the role of DTH in this process.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s13071-025-06941-6","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T19:01:56Z","timestamp":1754420516000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Systematic suppression of Leishmania (Leishmania) amazonensis-mediated delayed-type hypersensitivity response in American cutaneous leishmaniasis"],"prefix":"10.1186","volume":"18","author":[{"given":"Marliane B.","family":"Campos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana V. R.","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiago","family":"Vasconcelos dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia K.","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia M. C.","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rcia D.","family":"Laurenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos E. P.","family":"Corbett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey J.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando T.","family":"Silveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,5]]},"reference":[{"key":"6941_CR1","first-page":"13","volume":"1","author":"R Lainson","year":"2010","unstructured":"Lainson R. The Neotropical Leishmania species: a brief historical review of their discovery, ecology and taxonomy. Rev Pan-Amaz Sa\u00fade. 2010;1:13\u201338.","journal-title":"Rev Pan-Amaz Sa\u00fade"},{"key":"6941_CR2","first-page":"313","volume":"5","author":"R Lainson","year":"2010","unstructured":"Lainson R, Shaw JJ. New World Leishmaniasis. Parasitol. 2010;5:313\u201349.","journal-title":"Parasitol"},{"key":"6941_CR3","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.108967","author":"FT Silveira","year":"2023","unstructured":"Silveira FT, Campos MB, M\u00fcller SF, Ramos PK, Lima LV, dos Santos TV, et al. From biology to disease: importance of species-specific Leishmania Antigens from the subgenera Viannia (L braziliensis) and Leishmania (L amazonensis) in the pathogenesis of American cutaneous leishmaniasis. Leishmania Parasites. 2023. https:\/\/doi.org\/10.5772\/intechopen.108967.","journal-title":"Leishmania Parasites."},{"key":"6941_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1051\/parasite\/2014039","volume":"21","author":"YL Jennings","year":"2014","unstructured":"Jennings YL, de Souza AA, Ishikawa EA, Shaw JJ, Lainson R, Silveira FT. Phenotypic characterization of Leishmania spp. causing cutaneous leishmaniasis in the lower Amazon region, western Par\u00e1 state, Brazil reveals a putative hybrid parasite Leishmania (Viannia) guyanensis x Leishmania (Viannia) shawi shawi. Parasite. 2014;21:1\u201311.","journal-title":"Parasite"},{"key":"6941_CR5","doi-asserted-by":"publisher","DOI":"10.1590\/1678-4685-GMB-2020-0123","volume":"44","author":"ACS Lima","year":"2021","unstructured":"Lima ACS, Gomes CMC, Tomokane TY, Campos MB, Zampieri RA, Jorge CL, et al. Molecular tools confirm natural Leishmania (Viannia) guyanensis\/L. (V.) shawi hybrids causing cutaneous leishmaniasis in the Amazon region of Brazil. Gen Mol Biology. 2021;44:e20200123. https:\/\/doi.org\/10.1590\/1678-4685-GMB-2020-0123.","journal-title":"Gen Mol Biology"},{"key":"6941_CR6","first-page":"411","volume":"25","author":"G Vianna","year":"1911","unstructured":"Vianna G. Sobre uma nova esp\u00e9cie de Leishmania (nota preliminar). Brasil M\u00e9dico. 1911;25:411\u20131911.","journal-title":"Brasil M\u00e9dico"},{"key":"6941_CR7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/oxfordjournals.bmb.a070892","volume":"28","author":"R Lainson","year":"1972","unstructured":"Lainson R, Shaw JJ. Leishmaniasis of the New World: taxonomic problems. Brit Med Bull. 1972;28:44\u20138.","journal-title":"Brit Med Bull"},{"key":"6941_CR8","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1590\/S0074-02762004000300001","volume":"99","author":"FT Silveira","year":"2004","unstructured":"Silveira FT, Lainson R, Corbert CEP. Clinical and immunopathological spectrum of American cutaneous leishmaniasis with special reference to the disease in the Amazonian Brazil. Mem Inst Oswaldo Cruz. 2004;99:239\u201351.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"6941_CR9","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/j.1365-3024.2009.01116.x","volume":"31","author":"FT Silveira","year":"2009","unstructured":"Silveira FT, Lainson R, Gomes CM, et al. Immunopathogenic competences of Leishmania (V.) braziliensis and L. (L.) amazonensis in American cutaneous leishmaniasis. Parasite Immunol. 2009;31:423\u201331.","journal-title":"Parasite Immunol"},{"key":"6941_CR10","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/trstmh\/trz037","volume":"113","author":"FT Silveira","year":"2019","unstructured":"Silveira FT. What makes mucosal and anergic diffuse cutaneous leishmaniases so clinically and immunopathologically different? Trans Roy Soc Trop Med Hyg. 2019;113:505\u201316.","journal-title":"Trans Roy Soc Trop Med Hyg"},{"key":"6941_CR11","first-page":"9","volume":"22","author":"FT Silveira","year":"2008","unstructured":"Silveira FT, M\u00fcller SFR, de Souza AAA, Lainson R, Gomes CMC, Laurent MD, et al. Pathogenesis review of American cutaneous leishmaniasis in the Amazon, with emphasis on the disease caused by Leishmania (V.) braziliensis and Leishmania (L.) amazonensis. Revista Paraense de Medicina (Med J of Par\u00e1 State, Brazil). 2008;22:9\u201320.","journal-title":"Revista Paraense de Medicina (Med J of Par\u00e1 State, Brazil)"},{"key":"6941_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0194383","volume":"13","author":"MB Campos","year":"2018","unstructured":"Campos MB, Lima LVR, de Lima ACS, dos Santos TV, Ramos PKS, Gomes CM, et al. Toll-like receptors 2, 4, and 9 expressions over the entire clinical and immunopathological spectrum of American cutaneous leishmaniasis due to Leishmania (V.) braziliensis and Leishmania (L.) amazonensis. PLoS ONE. 2018;13:e0194383. https:\/\/doi.org\/10.1371\/journal.pone.0194383.","journal-title":"PLoS ONE"},{"key":"6941_CR13","first-page":"124","volume":"83","author":"R Lainson","year":"1986","unstructured":"Lainson R, Shaw JJ, Silveira FT, Braga RR, Ryan L, Povoa MM, et al. A Leishmania e as leishmanioses. Funda\u00e7\u00e3o Servi\u00e7os de Sa\u00fade P\u00fablica. 1986;83:124.","journal-title":"Funda\u00e7\u00e3o Servi\u00e7os de Sa\u00fade P\u00fablica"},{"key":"6941_CR14","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/0035-9203(91)90437-4","volume":"85","author":"FT Silveira","year":"1991","unstructured":"Silveira FT, Lainson R, Shaw JJ, de Souza AAA, Ishikawa EA, Braga RR. Cutaneous leishmaniasis due to Leishmania (Leishmania) amazonensis in Amazonian Brazil, and the significance of a Montenegro skin-test in human infections. Trans Roy Soc Trop Med Hyg. 1991;85:735\u20138.","journal-title":"Trans Roy Soc Trop Med Hyg"},{"key":"6941_CR15","first-page":"1691","volume":"72","author":"FT Silveira","year":"2018","unstructured":"Silveira FT, Muller SFR, Laurenti MD, Gomes CMC, Corbett CEP. Leishmaniose Tegumentar Americana. Tratado de Dermatolog\u00eda. 2018;72:1691\u2013700.","journal-title":"Tratado de Dermatolog\u00eda"},{"key":"6941_CR16","unstructured":"Ferreira VQ, Morais TG, Silveira FT, Campos MB. Evaluation of Montenegro skin test and the therapeutic response to American cutaneous leishmaniasis in clinical cases caused by Leishmania (L.) amazonensis. In: 58 Con Soc Bras Med Trop (Eixo 6, Protozooses), 2023; Salvador, Bahia, Brasil."},{"key":"6941_CR17","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1590\/S0074-02762005000500013","volume":"100","author":"FT Silveira","year":"2005","unstructured":"Silveira FT, Lainson R, Corbett CEP. Further observations on clinical, histopathological and immunological features of borderline disseminated cutaneous leishmaniasis caused by Leishmania (Leishmania) amazonensis. Mem Inst Oswaldo Cruz. 2005;100:525\u201334.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"6941_CR18","first-page":"25","volume":"79","author":"FT Silveira","year":"2009","unstructured":"Silveira FT. Leishmaniose cut\u00e2nea difusa na Amaz\u00f4nia, Brasil: aspectos cl\u00ednicos e epidemiol\u00f3gicos. Gaz M\u00e9d Bahia. 2009;79:25\u20139.","journal-title":"Gaz M\u00e9d Bahia"},{"key":"6941_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1046\/j.1365-3024.1998.t01-1-00126.x","volume":"20","author":"FT Silveira","year":"1998","unstructured":"Silveira FT, Blackwell JM, Ishikawa EA, Braga RR, Shaw JJ, Quinnell RJ, et al. T cell responses to crude and defined leishmanial antigens in patients from the lower Amazon region of Brazil infected with different species of Leishmania of the subgenera Leishmania and Viannia. Parasite Immunol. 1998;20:19\u201326.","journal-title":"Parasite Immunol"},{"key":"6941_CR20","doi-asserted-by":"publisher","DOI":"10.1590\/0037-8682-0255-2020","author":"LP Gon\u00e7alves","year":"2020","unstructured":"Gon\u00e7alves LP, Vasconcelos dos Santos T, Campos MB, Lima LVR, Ishikawa EAY, Silveira FT, et al. Further insights into the eco-epidemiology of American cutaneous leishmaniasis in the Belem metropolitan region Par\u00e1 State Brazil. Rev Soc Bras Med Trop. 2020. https:\/\/doi.org\/10.1590\/0037-8682-0255-2020.","journal-title":"Rev Soc Bras Med Trop"},{"key":"6941_CR21","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/sj.gene.6364422","volume":"8","author":"SMB Jeronimo","year":"2007","unstructured":"Jeronimo SMB, Holst AK, Jamieson SE, Francis R, Bezerra FL, Ettinger NA, et al. Genes at human chromosome 5q31.1 regulate delayed-type hypersensitivity responses associated with Leishmania chagasi infection. Genes Immunol. 2007;8:539\u201351.","journal-title":"Genes Immunol"},{"key":"6941_CR22","unstructured":"Silveira FT, Lainson R, Muller SFR, de Souza AAA, Corbett CEP. Leishmaniose tegumentar americana. In: Medicina Tropical e Infectologia na Amaz\u00f4nia. RNG Le\u00e3o (Ed). Ed. Samauma, 1ed.Vol. 2, Instituto Evandro Chagas, Bel\u00e9m, Par\u00e1, Brasil 2013;1203\u201344."},{"key":"6941_CR23","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade (MS), Secretaria de Vigil\u00e2ncia da Sa\u00fade (SVS), Dep. de Vigil\u00e2ncia das Doen\u00e7as Transmiss\u00edveis (DVDT). Manual de vigil\u00e2ncia da leishmaniose tegumentar. Bras\u00edlia. 2017."},{"key":"6941_CR24","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/0035-9203(75)90127-3","volume":"69","author":"J Shaw","year":"1975","unstructured":"Shaw J, Lainson R. Leishmaniasis in Brazil: X. Some observations on intradermal reactions to different trypanosomatid antigens of patients suffering from cutaneous and mucocutaneous leishmaniasis. Trans Roy Soc Trop Med Hyg. 1975;69:323\u201335.","journal-title":"Trans Roy Soc Trop Med Hyg."},{"key":"6941_CR25","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1001\/archderm.1926.02370140053003","volume":"13","author":"J Montenegro","year":"1926","unstructured":"Montenegro J. Cutaneous reaction in leishmaniasis. Arch Dermatol Syphil. 1926;13:187\u201394.","journal-title":"Arch Dermatol Syphil"},{"key":"6941_CR26","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1586\/eri.10.19","volume":"8","author":"H Goto","year":"2010","unstructured":"Goto H, Lindoso JA. Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis. Expert Rev Anti Infect Ther. 2010;8:419\u201333. https:\/\/doi.org\/10.1586\/eri.10.19.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"6941_CR27","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1590\/0037-8682-0067-2015","volume":"48","author":"CM Skraba","year":"2015","unstructured":"Skraba CM, Perles de Mello TF, Pedroso RB, Ferreira EC, Demarchi IG, Aristides SMA, et al. Evaluation of the reference value for the Montenegro skin test. Rev Soc Bras Med Trop. 2015;48:437\u201344. https:\/\/doi.org\/10.1590\/0037-8682-0067-2015.","journal-title":"Rev Soc Bras Med Trop"},{"key":"6941_CR28","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw670","author":"N Aronson","year":"2016","unstructured":"Aronson N, Herwaldt BL, Libman M, Pearson R, Lopez-velez R, Weina P, et al. Diagnosis and treatment of leishmaniasis: clinical practice guidelines by the infectious diseases society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Clin Infect Dis. 2016. https:\/\/doi.org\/10.1093\/cid\/ciw670.","journal-title":"Clin Infect Dis"},{"key":"6941_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pntd.0009531","volume":"15","author":"J Carstens-Kass","year":"2021","unstructured":"Carstens-Kass J, Paulini K, Lypaczewski P, Matiashewski G. A review of the leishmanin skin test: a neglected test for a neglected disease. PLoS Neglec Trop Dis. 2021;15:1\u201316.","journal-title":"PLoS Neglec Trop Dis"},{"key":"6941_CR30","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/0035-9203(75)90012-7","volume":"69","author":"S Pampiglione","year":"1975","unstructured":"Pampiglione S, Manson-Bahr PEC, La Placa M, Borgatti MA, Musumeci S. Studies in Mediterranean leishmaniasis: 3. The leishmanin skin test in kala-azar. Trans R Soc Trop Med Hyg. 1975;69:60\u20138.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"6941_CR31","doi-asserted-by":"publisher","first-page":"79","DOI":"10.4269\/ajtmh.1986.35.79","volume":"35","author":"SG Reed","year":"1986","unstructured":"Reed SG, Badar\u00f3 R, Masur H, Carvalho EM, Loren\u00e7o R, Lisboa A, et al. Selection of a skin test antigen for American visceral leishmaniasis. Am J Trop Med Hyg. 1986;35:79\u201385.","journal-title":"Am J Trop Med Hyg"},{"key":"6941_CR32","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1093\/infdis\/154.6.1003","volume":"154","author":"R Badar\u00f3","year":"1986","unstructured":"Badar\u00f3 R, Jones TC, Carvalho EM, Sampaio D, Reed SG, Barral A, et al. New perspectives on a subclinical form of visceral leishmaniasis. J Infec Dis. 1986;154:1003\u201312.","journal-title":"J Infec Dis"},{"key":"6941_CR33","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1017\/S0031182099004680","volume":"119","author":"CR Davies","year":"1999","unstructured":"Davies CR, Mazloumi GAS. Age, acquired immunity and the risk of visceral leishmaniasis: a prospective study in Iran. Parasitol. 1999;119:247\u201357.","journal-title":"Parasitol"},{"key":"6941_CR34","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1080\/00034983.1993.11812749","volume":"87","author":"A Ali","year":"1993","unstructured":"Ali A, Ashford RW. Visceral leishmaniasis in Ethiopia. I. Crosssectional leishmanin skin test in an endemic locality. Ann Trop Med Parasitol. 1993;87:157\u201361.","journal-title":"Ann Trop Med Parasitol"},{"key":"6941_CR35","doi-asserted-by":"publisher","first-page":"826","DOI":"10.4269\/ajtmh.1994.51.826","volume":"51","author":"EE Zijlstra","year":"1994","unstructured":"Zijlstra EE, El-Hassan AM, Ismael A, Ghalib HW. Endemic kala-azar in eastern Sudan: a longitudinal study on the incidence of clinical and subclinical infection and post-kala-azar dermal leishmaniasis. Am J Trop Med Hyg. 1994;51:826\u201336.","journal-title":"Am J Trop Med Hyg"},{"key":"6941_CR36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1046\/j.1365-3156.2002.00832.x","volume":"7","author":"EA Khalil","year":"2001","unstructured":"Khalil EA, Zijlstra EE, Kager PA, El Hassan AM. Epidemiology and clinical manifestations of Leishmania donovani infection in two villages in an endemic area in eastern Sudan. Trop Med Int Health. 2001;7:35\u201344.","journal-title":"Trop Med Int Health"},{"key":"6941_CR37","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0035-9203(02)90278-6","volume":"96","author":"L Moral","year":"2002","unstructured":"Moral L, Rubio EM, Moya M. A leishmanin skin test survey in the human population of l\u2019Alacanti region (Spain): implications for the epidemiology of Leishmania infantum infection in southern Europe. Trans R Soc Trop Med Hyg. 2002;96:129\u201332.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"6941_CR38","doi-asserted-by":"publisher","first-page":"909","DOI":"10.4269\/ajtmh.2007.76.909","volume":"76","author":"C Bern","year":"2007","unstructured":"Bern C, Haque R, Chowdhury R, Ali M, Kurkjian KM, Vaz L, et al. The epidemiology of visceral leishmaniasis and asymptomatic leishmanial infection in a highly endemic Bangladeshi village. Am J Trop Med Hyg. 2007;76:909\u201314.","journal-title":"Am J Trop Med Hyg"},{"key":"6941_CR39","doi-asserted-by":"publisher","first-page":"502","DOI":"10.4269\/ajtmh.2010.09-0345","volume":"83","author":"RK Topno","year":"2010","unstructured":"Topno RK, Das VN, Ranjan A, Pandey K, Singh D, Kumar N, et al. Asymptomatic infection with visceral leishmaniasis in a disease-endemic area in Bihar. India Am J Trop Med Hyg. 2010;83:502\u20136.","journal-title":"India Am J Trop Med Hyg"},{"key":"6941_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001284","volume":"5","author":"B Ostyn","year":"2011","unstructured":"Ostyn B, Gidwani K, Khanal B, Picado A, Chappuis F, Singh SP, et al. Incidence of symptomatic and asymptomatic Leishmania donovani infections in high-endemic foci in India and Nepal: a prospective study. PLoS Negl Trop Dis. 2011;5:e1284.","journal-title":"PLoS Negl Trop Dis"},{"key":"6941_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002053","volume":"7","author":"E Hasker","year":"2013","unstructured":"Hasker E, Kansal S, Malaviya P, Gidwani K, Picado A, Singh RP, et al. Latent infection with Leishmania donovani in highly endemic villages in Bihar. India PLoS Negl Trop Dis. 2013;7:e2053.","journal-title":"India PLoS Negl Trop Dis"},{"key":"6941_CR42","first-page":"3","volume":"33","author":"D Silva","year":"1958","unstructured":"Silva D. Leishmaniose tegumentar queloidiana com les\u00f5es \u00f3sseas. An Bras Derm Sif. 1958;33:3\u20137.","journal-title":"An Bras Derm Sif"},{"key":"6941_CR43","first-page":"493","volume":"14","author":"D Silva","year":"1972","unstructured":"Silva D, Maroja R, Salgado U, Loureiro A. Leishmaniose an\u00e9rgica hanseno\u00edde. Derm Iber Lat Amer. 1972;14:493\u2013506.","journal-title":"Derm Iber Lat Amer"},{"key":"6941_CR44","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1590\/S0074-02761948000200003","volume":"46","author":"PL Barrientos","year":"1948","unstructured":"Barrientos PL. Um caso at\u00edpico de leishmaniose cut\u00e2neo-mucosa. Mem Inst Oswaldo Cruz. 1948;46:415\u20138.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"6941_CR45","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1001\/archderm.1957.01550200057012","volume":"76","author":"J Convit","year":"1957","unstructured":"Convit J, Reyes O, Kerdel F. Disseminated anergic American leishamniasis. AMA Arch Derm. 1957;76:213\u20137.","journal-title":"AMA Arch Derm"},{"key":"6941_CR46","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/0035-9203(72)90306-9","volume":"66","author":"J Convit","year":"1972","unstructured":"Convit J, Pinardi ME, Rondon AJ. Diffuse cutaneous leishmaniasis: a disease due to an immunological defect of the host. Trans Roy Soc Trop Med Hyg. 1972;66:603\u201310.","journal-title":"Trans Roy Soc Trop Med Hyg"},{"key":"6941_CR47","doi-asserted-by":"crossref","unstructured":"Moraes MAP, Silveira FT. Histopatology of localized form of cutaneous leishmaniasis caused by Leishmania (Leishmania) amazonensis. Rev Inst Med Trop S\u00e3o Paulo. 1994;36:459\u201363.","DOI":"10.1590\/S0036-46651994000500011"},{"key":"6941_CR48","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1590\/S0036-46651986000500004","volume":"28","author":"AV Magalh\u00e3es","year":"1986","unstructured":"Magalh\u00e3es AV, Moraes MAP, Raick NA, Llanos-Cuentas A, Costa JM, Cuba CC, et al. Histopatologia da Leishmaniose Tegumentar por Leishmania braziliensis braziliensis: 3. Rea\u00e7\u00e3o celular nos tecidos. Rev Inst Med Trop S\u00e3o Paulo. 1986;28:300\u201311.","journal-title":"Rev Inst Med Trop S\u00e3o Paulo"},{"key":"6941_CR49","unstructured":"Schubach A. Assessment of Parasite Persistence in the Skin of Patients with American Cutaneous Leishmaniasis. Thesis: Postgraduate Studies in Parasitic Biology - Institute Oswaldo Cruz, FIOCRUZ, Rio de Janeiro, 1997;184."},{"key":"6941_CR50","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1998.58.824Volume","author":"A Schubach","year":"1998","unstructured":"Schubach A, Marzochi MC, Cuzzi-Maya T, Oliveira AV, Araujo ML, Oliveira AL, et al. Cutaneous scars in American tegumentary leishmaniasis patients: a site of Leishmania (Viannia) braziliensis persistence and viability eleven years after antimonial therapy and clinical cure. Am J Trop Med Hygiene. 1998. https:\/\/doi.org\/10.4269\/ajtmh.1998.58.824Volume.","journal-title":"Am J Trop Med Hygiene"},{"key":"6941_CR51","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s40257-015-0114-z","volume":"16","author":"HJC De Vries","year":"2015","unstructured":"De Vries HJC, Reedijk SH, Schallig HDFH. Cutaneous leishmaniasis: recent developments in diagnosis and management. Am J Clin Dermatol. 2015;16:99\u2013109. https:\/\/doi.org\/10.1007\/s40257-015-0114-z.","journal-title":"Am J Clin Dermatol"},{"key":"6941_CR52","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1086\/521682","volume":"196","author":"SMB Jeronimo","year":"2007","unstructured":"Jeronimo SMB, Duggal P, Ettinger NA, Nascimento ET, Monteiro GR, Cabral AP, et al. Genetic predisposition to self-curing infection with the protozoan Leishmania chagasi: a genome wide scan. J Infect Dis. 2007;196:1261\u20139. https:\/\/doi.org\/10.1086\/521682.","journal-title":"J Infect Dis"},{"key":"6941_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007216","volume":"13","author":"L Chakravarty","year":"2019","unstructured":"Chakravarty L, Hasker E, Kansal S, Singh OP, Malavyia P, Singh AK, et al. Determinants for progression from asymptomatic infection to symptomatic visceral leishmaniasis: a cohort study. PLoS Negl Trop Dis. 2019;13:e0007216. https:\/\/doi.org\/10.1371\/journal.pntd.0007216.","journal-title":"PLoS Negl Trop Dis."},{"key":"6941_CR54","doi-asserted-by":"publisher","first-page":"653","DOI":"10.3390\/microorganisms11030653","volume":"11","author":"VLR Da Matta","year":"2023","unstructured":"Da Matta VLR, Gon\u00e7alves NA, Gomes CMC, Chouman IH, Ferreira FM, Campos MB, et al. Gene signatures of symptomatic and asymptomatic clinical-immunological profiles of human infection by Leishmania (L.) chagasi in Amazonian Brazil. Microorganisms. 2023;11:653. https:\/\/doi.org\/10.3390\/microorganisms11030653.","journal-title":"Microorganisms"},{"key":"6941_CR55","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/0035-9203(74)90067-4","volume":"68","author":"S Pampiglione","year":"1974","unstructured":"Pampiglione S, Manson-Bahr PEC, Giungi F, Giunti G, Parenti A, Canestri TG. Studies on Mediterranean leishmaniasis 2. Asymptomatic cases of visceral leishmaniasis. Trans R Soc Trop Med Hyg. 1974;68:447\u201353.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"6941_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF00718599","volume":"415","author":"MIS Duarte","year":"1989","unstructured":"Duarte MIS, Mariano ON, Corbett CEP. Liver parenchymal cell parasitism in human visceral leishmaniasis. Virchows Arch. 1989;415:1\u20136.","journal-title":"Virchows Arch"},{"key":"6941_CR57","first-page":"16","volume":"79","author":"JM Costa","year":"2009","unstructured":"Costa JM, Uthant AA, Elkhoury NA, Bezerril ACR, Barral A, Saldanha ACR. Leishmaniose cut\u00e2nea difusa (LCD) no Brasil ap\u00f3s 60 anos de sua primeira descri\u00e7\u00e3o. Gaz M\u00e9d Bahia. 2009;79:16\u201324.","journal-title":"Gaz M\u00e9d Bahia"},{"key":"6941_CR58","unstructured":"Campos MB, Lima LV, dos Santos TV, Ramos PKS, Lima ACS, Gomes CM, Silveira FT. CD8+ T-cells showed greater prominence than CD4+ T-cells to antimony therapy in any of the clinical forms of cutaneous leishmaniasis caused by Leishmania (L.) amazonensis. In: The 7th World Leishmaniasis Congress 2022; Cartagena, Colombia."},{"key":"6941_CR59","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/j.1365-3024.2012.01370.x","volume":"34","author":"AK Carvalho","year":"2012","unstructured":"Carvalho AK, Silveira FT, Passero LFD, Gomes CMC, Corbett CE, Laurenti MD. Leishmania (V.) braziliensis and L. (L.) amazonensis promote differential expression of dendritic cells and cellular immune response in murine model. Parasite Immunol. 2012;34:395\u2013403. https:\/\/doi.org\/10.1111\/j.1365-3024.2012.01370.x.","journal-title":"Parasite Immunol"},{"key":"6941_CR60","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/7068287","author":"AK Carvalho","year":"2016","unstructured":"Carvalho AK, Carvalho K, Passero LFD, Sousa MGT, da Matta VLR, Gomes CM, et al. Differential recruitment of dendritic cells subsets to lymph nodes correlates with a protective or permissive T-cell response during Leishmania (Viannia) braziliensis or Leishmania (Leishmania) amazonensis infection. Med Inflamm. 2016. https:\/\/doi.org\/10.1155\/2016\/7068287.","journal-title":"Med Inflamm"},{"key":"6941_CR61","first-page":"26","volume":"32","author":"E Chagas","year":"1999","unstructured":"Chagas E, Corr\u00eaa C, Silveira F. Avalia\u00e7\u00e3o da resposta imune humoral atrav\u00e9s do teste de imunofluoresc\u00eancia indireta na leishmaniose cut\u00e2nea causada por Leishmania (L.) amazonensis na regi\u00e3o Amaz\u00f4nica do Brasil. Rev Soc Bras Med Trop. 1999;32:26.","journal-title":"Rev Soc Bras Med Trop"},{"key":"6941_CR62","unstructured":"Chagas E, Ishikawa E, Silveira F. Humoral response (IgG) in the borderline disseminated cutaneous leishmaniasis (BDCL) caused by Leishmania (L.) amazonensis in Par\u00e1 State Brazil. WOLRD leish2 Crete Greece. 2001;226:118."},{"key":"6941_CR63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007152","volume":"13","author":"SM Christensen","year":"2019","unstructured":"Christensen SM, Belew AT, El-Sayed NM, Tafuri WL, Silveira FT, Mosser DM. Host parasite responses in human diffuse cutaneous leishmaniasis caused by L. amazonensis. PLoS Neglec Trop Dis. 2019;13:e0007152. https:\/\/doi.org\/10.1371\/journal.pntd.0007152.","journal-title":"PLoS Neglec Trop Dis"},{"key":"6941_CR64","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1186\/s13071-024-06486-0","volume":"17","author":"LV Melo","year":"2024","unstructured":"Melo LV, Vasconcelos dos Santos T, Ramos PK, Lima LV, Campos MB, Silveira FT. Antigenic reactivity of Leishmania (Viannia) lainsoni axenic amastigote proved to be a suitable alternative for optimizing Montenegro skin test. Parasites Vectors. 2024;17:402. https:\/\/doi.org\/10.1186\/s13071-024-06486-0.","journal-title":"Parasites Vectors"},{"key":"6941_CR65","first-page":"129","volume":"42","author":"FT Silveira","year":"1997","unstructured":"Silveira FT, Mayrink W. Leishmaniose cut\u00e2nea an\u00e9rgica difusa no Estado do Par\u00e1, Brasil: relato da cura de um caso depois de 24 anos de doen\u00e7a, ap\u00f3s tratamento combinado de quimioterapia com imunoterapia. Cong Soc Bras Med Trop. 1997;42:129.","journal-title":"Cong Soc Bras Med Trop"},{"key":"6941_CR66","doi-asserted-by":"publisher","first-page":"890","DOI":"10.3390\/pathogens12070890","volume":"12","author":"SVCB Gon\u00e7alves","year":"2023","unstructured":"Gon\u00e7alves SVCB, Costa DL, Cantinho-Junior JdJ, Vieira-Junior JN, Ishikawa EAY, Costa RN, et al. The extraordinary case of a woman with a 30-year-long diffuse leishmaniasis cured with one single ampoule of intranasal pentavalent antimoniate. Pathogens. 2023;12:890. https:\/\/doi.org\/10.3390\/pathogens12070890.","journal-title":"Pathogens"},{"key":"6941_CR67","doi-asserted-by":"publisher","unstructured":"Silveira FT. Leishmania (L.) amazonensis Lainson & Shaw 1972 A cruel parasite causing a high-morbidity disease with severe physical deformities and secondarily, even death. Rev Soc Bras Med Trop. 2025. https:\/\/doi.org\/10.1590\/0037-8682-0393-2024.","DOI":"10.1590\/0037-8682-0393-2024"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-025-06941-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-025-06941-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-025-06941-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T19:07:22Z","timestamp":1757358442000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-025-06941-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,5]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6941"],"URL":"https:\/\/doi.org\/10.1186\/s13071-025-06941-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6430838\/v1","asserted-by":"object"}]},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,5]]},"assertion":[{"value":"11 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants were provided with a detailed explanation regarding the objective of the study. Written informed consent (WICF) was obtained from all participants. WICF was obtained from the participant and the guardian (free and informed assent term [FIAT]) in the case of participants aged\u2009<\u200918\u00a0years. The study protocol was approved by the Ethics Research Committee of the Medicine School of S\u00e3o Paulo University, S\u00e3o Paulo State, Brazil, with protocol number CAAE: 03952418.3.0000.0065.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"336"}}